• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反应参数对用于药物递送的环糊精基纳米结构聚合物合成的影响。

Effect of Reaction Parameters on the Synthesis of Cyclodextrin-Based Nanostructured Polymers for Drug Delivery.

作者信息

Salgın Sema, Eke Hasan Hüseyin, Soyer Nagihan, Salgın Uğur

机构信息

Department of Chemical Engineering, Faculty of Engineering, Sivas Cumhuriyet University, 58140 Sivas, Turkey.

Farma-Tek Pharmaceutical Industry and Trade Inc., 39100 Kırklareli, Turkey.

出版信息

Polymers (Basel). 2025 Mar 7;17(6):709. doi: 10.3390/polym17060709.

DOI:10.3390/polym17060709
PMID:40292530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944358/
Abstract

In this study, cyclodextrin-based nanostructures (CDNSs) were synthesized through the cross-linking of cyclodextrin (CD) with epichlorohydrin (ECH) as a cross-linker. Two types of CDNSs, α-CDNS and β-CDNS, were prepared to systematically investigate the influence of reaction parameters-such as the solubilization time of α-CD and β-CD, the molar ratio of ECH to CD, and NaOH concentration-on the physicochemical properties of the final product. Naproxen (NAP), a poorly water-soluble drug, was selected as a model compound to assess the drug-loading capacity of the synthesized CDNSs. The effect of each reaction parameter on NAP integration into the CDNSs was examined at varying weight ratios. The optimal reaction conditions were determined to be a solubilization time of 6 h, an ECH/CD molar ratio of 8/1, and an NaOH concentration of 33%. Under these conditions, the NAP loading efficiency of α-CDNSs was calculated as 67.12%. Comparative analysis revealed that α-CDNSs outperformed β-CDNSs in terms of drug-loading capacity. Additionally, the synthesized CDNSs and NAP-loaded CDNSs were characterized using FTIR, DSC, XRD, SEM, and Zetasizer analyses, while the NAP concentration was determined by HPLC.

摘要

在本研究中,基于环糊精的纳米结构(CDNSs)通过环糊精(CD)与作为交联剂的环氧氯丙烷(ECH)交联合成。制备了两种类型的CDNSs,即α - CDNS和β - CDNS,以系统研究反应参数(如α - CD和β - CD的溶解时间、ECH与CD的摩尔比以及NaOH浓度)对最终产物物理化学性质的影响。选择难溶性药物萘普生(NAP)作为模型化合物,以评估合成的CDNSs的载药能力。在不同的重量比下,研究了每个反应参数对NAP整合到CDNSs中的影响。确定最佳反应条件为溶解时间6小时、ECH/CD摩尔比8/1以及NaOH浓度33%。在这些条件下,α - CDNSs的NAP负载效率计算为67.12%。对比分析表明,α - CDNSs在载药能力方面优于β - CDNSs。此外,使用傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)、X射线衍射(XRD)、扫描电子显微镜(SEM)和Zetasizer分析对合成的CDNSs和负载NAP的CDNSs进行了表征,同时通过高效液相色谱法(HPLC)测定了NAP浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c087dd9d0644/polymers-17-00709-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c1ca604828d3/polymers-17-00709-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/191f0af1dbb7/polymers-17-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/73d90af51e51/polymers-17-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c4fcb33bf507/polymers-17-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/003912873719/polymers-17-00709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/9e108a38450f/polymers-17-00709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/ac4f6c989f72/polymers-17-00709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/2bc1357c0972/polymers-17-00709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/bfdcb74597f8/polymers-17-00709-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c087dd9d0644/polymers-17-00709-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c1ca604828d3/polymers-17-00709-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/191f0af1dbb7/polymers-17-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/73d90af51e51/polymers-17-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c4fcb33bf507/polymers-17-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/003912873719/polymers-17-00709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/9e108a38450f/polymers-17-00709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/ac4f6c989f72/polymers-17-00709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/2bc1357c0972/polymers-17-00709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/bfdcb74597f8/polymers-17-00709-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1a/11944358/c087dd9d0644/polymers-17-00709-g009.jpg

相似文献

1
Effect of Reaction Parameters on the Synthesis of Cyclodextrin-Based Nanostructured Polymers for Drug Delivery.反应参数对用于药物递送的环糊精基纳米结构聚合物合成的影响。
Polymers (Basel). 2025 Mar 7;17(6):709. doi: 10.3390/polym17060709.
2
Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics.探索基于环糊精的纳米海绵作为药物传递系统:理解影响药物装载和释放动力学的物理化学因素。
Int J Mol Sci. 2024 Mar 20;25(6):3527. doi: 10.3390/ijms25063527.
3
Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery.制备和表征用于硼替佐米递送的环糊精纳米海绵。
Expert Opin Drug Deliv. 2020 Dec;17(12):1807-1816. doi: 10.1080/17425247.2020.1800637. Epub 2020 Nov 9.
4
Improved curcumin loading, release, solubility and toxicity by tuning the molar ratio of cross-linker to β-cyclodextrin.通过调节交联剂与β-环糊精的摩尔比来提高姜黄素的载药量、释放度、溶解度和降低毒性。
Carbohydr Polym. 2019 Jun 1;213:70-78. doi: 10.1016/j.carbpol.2019.02.075. Epub 2019 Feb 22.
5
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.一种新型口服给药系统,由“药物-环糊精-纳米结构脂质载体”组成,用于递送水中溶解度差的药物:长春西汀。
Int J Pharm. 2014 Apr 25;465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. Epub 2014 Feb 12.
6
Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.开发一种新的传递系统,由“药物-环糊精-纳米结构脂质载体”组成,用于酮洛芬的局部传递。
Eur J Pharm Biopharm. 2012 Jan;80(1):46-53. doi: 10.1016/j.ejpb.2011.07.015. Epub 2011 Aug 4.
7
Cationic β-cyclodextrin polymer applied to a dual cyclodextrin polyelectrolyte multilayer system.阳离子β-环糊精聚合物应用于双环糊精聚电解质多层体系。
Carbohydr Polym. 2015 Aug 1;126:156-67. doi: 10.1016/j.carbpol.2015.02.064. Epub 2015 Mar 18.
8
Diversity of β-cyclodextrin-based nanosponges for transformation of actives.基于 β-环糊精的纳米海绵的多样性用于活性转化。
Int J Pharm. 2019 Jun 30;565:333-350. doi: 10.1016/j.ijpharm.2019.05.015. Epub 2019 May 10.
9
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.基于水溶性阳离子β-环糊精聚合物的药物载体系统。
Int J Pharm. 2004 Jul 8;278(2):329-42. doi: 10.1016/j.ijpharm.2004.03.026.
10
Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers.基于环糊精-萘普生包合物的药物传递系统,该包合物被掺入电纺聚己内酯纳米纤维中。
Colloids Surf B Biointerfaces. 2014 Mar 1;115:15-21. doi: 10.1016/j.colsurfb.2013.11.021. Epub 2013 Nov 19.

引用本文的文献

1
Cyclodextrins as Multifunctional Platforms in Drug Delivery and Beyond: Structural Features, Functional Applications, and Future Trends.环糊精作为药物递送及其他领域的多功能平台:结构特征、功能应用及未来趋势
Molecules. 2025 Jul 20;30(14):3044. doi: 10.3390/molecules30143044.

本文引用的文献

1
Design, characterization, and evaluation of magnetic carboxymethylated β-cyclodextrin as a pH-sensitive carrier system for amantadine delivery: a novel approach for targeted drug delivery.磁性羧甲基化β-环糊精作为金刚烷胺递送的pH敏感载体系统的设计、表征及评价:一种靶向药物递送的新方法
RSC Adv. 2025 Jan 3;15(1):446-459. doi: 10.1039/d4ra06269h. eCollection 2025 Jan 2.
2
Engineered Porous Beta-Cyclodextrin-Loaded Raloxifene Framework with Potential Anticancer Activity: Physicochemical Characterization, Drug Release, and Cytotoxicity Studies.载雷洛昔芬多孔β-环糊精工程化骨架的潜在抗癌活性:理化性质表征、药物释放和细胞毒性研究。
Int J Nanomedicine. 2024 Nov 9;19:11561-11576. doi: 10.2147/IJN.S469570. eCollection 2024.
3
Recent Advances in Cyclodextrin-Based Nanoscale Drug Delivery Systems.
环糊精为基础的纳米药物传递系统的最新进展。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Nov-Dec;16(6):e1995. doi: 10.1002/wnan.1995.
4
Investigation of Host-Guest Inclusion Complex of Mephenesin with α-Cyclodextrin for Innovative Application in Biological System.甲芬那酸与α-环糊精的主客体包合物在生物系统中的创新应用研究。
ACS Omega. 2024 Aug 15;9(34):36066-36075. doi: 10.1021/acsomega.3c08185. eCollection 2024 Aug 27.
5
New methods of modification of α-cyclodextrin.α-环糊精的新型改性方法
Org Biomol Chem. 2024 Sep 11;22(35):7092-7102. doi: 10.1039/d4ob01109k.
6
Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics.探索基于环糊精的纳米海绵作为药物传递系统:理解影响药物装载和释放动力学的物理化学因素。
Int J Mol Sci. 2024 Mar 20;25(6):3527. doi: 10.3390/ijms25063527.
7
Nanosponge: A promising and intriguing strategy in medical and pharmaceutical Science.纳米海绵:医学和制药科学中一种有前景且引人入胜的策略。
Heliyon. 2023 Dec 6;10(1):e23303. doi: 10.1016/j.heliyon.2023.e23303. eCollection 2024 Jan 15.
8
Preparation and evaluation of βcyclodextrin-based nanosponges loaded with Budesonide for pulmonary delivery.制备并评价载布地奈德的β-环糊精纳米海绵用于肺部给药。
Int J Pharm. 2023 Nov 25;647:123529. doi: 10.1016/j.ijpharm.2023.123529. Epub 2023 Oct 17.
9
Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects.用于提高药物生物利用度和活性的环糊精包合物:合成与分析方面
Pharmaceutics. 2023 Sep 19;15(9):2345. doi: 10.3390/pharmaceutics15092345.
10
Cyclodextrins and Their Derivatives as Drug Stability Modifiers.环糊精及其衍生物作为药物稳定性调节剂
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1074. doi: 10.3390/ph16081074.